Digitisation | April 05, 2023
Dozee Raises $6 million to bolster its ambition of ‘HarBedDozeeBed’
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
A funding to expand operations and provide better patient care
Natural Capsules Limited's shareholding will be reduced to 89.99%
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards
Subscribe To Our Newsletter & Stay Updated
